Effect of ramosetron on QTc interval: a randomised controlled trial in patients undergoing off-pump coronary artery bypass surgery

BACKGROUND: Ramosetron is a relatively new 5-hydroxytryptamine three receptor antagonist with higher binding affinity and more prolonged duration of action compared to ondansetron. The present study was performed to evaluate the effects of ramosetron on QTc interval and possible cardiovascular adver...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:BMC Anesthesiol
Huvudupphovsmän: Kim, Tae Kyong, Cho, Youn Joung, Lim, Chae-won, Min, Jeong Jin, Choi, Eue-Keun, Hong, Deok Man, Jeon, Yunseok
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2016
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4972982/
https://ncbi.nlm.nih.gov/pubmed/27488394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12871-016-0222-1
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk